
Children’s Hospital of Philadelphia and Stanford University School of Medicine will lead the $5.4 million study ,with patient recruitment beginning in late 2021 or early 2022.

Children’s Hospital of Philadelphia and Stanford University School of Medicine will lead the $5.4 million study ,with patient recruitment beginning in late 2021 or early 2022.

CXL is safe, effective to perform on younger population, study results show.

Led by eye care nonprofit Orbis with support from Alcon, the training will build eye care professionals' skills to treat retinopathy of prematurity in Latin America

A new study reveals that children of mothers with diabetes during pregnancy have an increased risk of eye problems.

Most patients with allergic disorder are children, adolescents, or young adults.

Edward Manche, MD, discusses results from his presentation regarding outcomes of corneal crosslinking keratoconus in a pediatric population.

Focus on maximizing visual examination by combining methods of detection-based testing.

According to investigators, the system has been shown to almost triple the number of people with eye problems attending primary care, as well as increasing appropriate uptake of hospital services.

According to investigators, infants may have an edge over adults, with babies demonstrating a stronger immune response to the SARS-CoV-2 virus.

The event, being held at the Mandalay Bay Resort and Casino in Las Vegas, is offering a full agenda for in-person attendees.

Vyluma Inc. will focus on the development and commercialization of therapies to treat ophthalmic diseases, including pediatric myopia.

Investigators find increased treatment regimen is effective and long-lasting for patients.


Community involvement, research continue to boost treatment in pediatric population.

Nine pediatric patients with Leber congenital amaurosis show visual improvement in clinical trials.

New paradigm-changing treatments for young patients on the horizon.








